SHBG (sex hormone-binding globulin) and blood sugar are linked through insulin metabolism. Low SHBG levels are consistently associated with insulin resistance, elevated fasting glucose, and increased type 2 diabetes risk. Insulin suppresses hepatic SHBG production, so hyperinsulinemia (e.g., in metabolic syndrome) lowers SHBG. Conversely, low SHBG may serve as an early marker of impaired glucose tolerance. Evidence comes from epidemiological and mechanistic studies, but SHBG is not a routine clinical marker for glycemic control. MyBody-X includes SHBG in hormone or metabolism panels, but interpretation requires context (HbA1c, fasting glucose, insulin). An isolated low SHBG does not diagnose diabetes. Lifestyle changes like weight loss and exercise can raise SHBG and improve insulin sensitivity. Caveat: SHBG is also influenced by estrogens, thyroid hormones, and liver disease. Evidence is moderate – many human studies but no RCTs proving causality.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-c471e62138c60f536132ab55